PPD Inc., Rhone-Poulenc Rorer deal

PPDI’s PPD Discovery subsidiary and RPR will develop therapeutics for oncology, inflammation, cardiovascular disease and

Read the full 157 word article

How to gain access

Continue reading with a
two-week free trial.